Nick Seaver is a Managing Director at Ziff Capital Partners, primarily focused on direct private investments in biotech. He also serves as CFO/CBO of ZCP-backedCorner Therapeutics, a ZCP portfolio company developing next-generation vaccines for cancer and infectious disease. He has a background in private equity (JP Morgan Partners) and as an entrepreneur and operator (CEO of Thanyapura, a diversified holding company). He chairs the MED13L Foundation, dedicated to finding medicines for the rare condition MED13L. Nick is a graduate of Harvard College.
